Trials / Completed
CompletedNCT06193720
The Impact of Arnica Montana Following the Surgical Extraction of Impacted Third Molars
The Impact of Arnica Montana on Postoperative Pain, Swelling and Trismus Following the Surgical Extraction of Impacted Third Molars: A Split Mouth Randomized Clinical Double Blinded Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Saint-Joseph University · Academic / Other
- Sex
- All
- Age
- 16 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Aim: The aim of this study is to evaluate the action of the homeopathic plant Arnica Montana on postoperative edema, pain and trismus after surgical extraction of impacted wisdom teeth. Materials and Methods: The study is a double-blinded clinical trial recruiting patients undergoing surgical extraction of symmetrically impacted maxillary or mandibular third molars (right and left side). Patients receive alternately and randomly the verum (Arnica Montana 12 CH) or the placebo, in the form of capsules, to be taken 1 day prior to surgery and for 7 days postoperatively. Clinical parameters are collected and include: pain score, maximum mouth opening and facial measurements to assess edema's intensity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Arnica montana | Assess the effect of arnica montana on pain, swelling ans trismus after impacted third molar surgery |
| OTHER | Placebo | Patients will take placebo drug after surgeries |
Timeline
- Start date
- 2022-02-03
- Primary completion
- 2023-08-20
- Completion
- 2023-08-20
- First posted
- 2024-01-05
- Last updated
- 2024-01-05
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT06193720. Inclusion in this directory is not an endorsement.